{"name":"Noah Hahn, M.D.","slug":"noah-hahn-m-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNelY1am1kUUphUDFJc1JyM01lM0N2LXdfeVpRRF9maWFObFBGSUZubTNZX1lmVGxMb3FKUFhPVDhnUGpFek9nTFdOMDZSTGxUQWVfQXg5dVY4U2s3dzRCUUEwNUdtZ1hzc2hwQVpJdk9YYUNiZE8xSFhxWS1ib1J1TFBOYTNwbjhnWEtOaTdCZXZmTFV5SjZYT2lDa2dKSEs0UlZvNkhBUjN6al9OajRyYXM1NTZIa2ZTck53ejc5US1vZWdMZC03MjdESQ?oc=5","date":"2025-11-07","type":"pipeline","source":"Johns Hopkins Medicine","summary":"GBCI 2.0: Hahn and Kates Lead New Era for the Greenberg Bladder Cancer Institute - Johns Hopkins Medicine","headline":"GBCI 2.0: Hahn and Kates Lead New Era for the Greenberg Bladder Cancer Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNdTNfZEtwNy1BUGY3cmFEVXpBaEpVOEZnTWFjNE4zQm5LeTQ1TEgtSjdyaTNaZlFOeXVyX1djbWI4SVBKSFY1cG40TkdPd3c5aWNkN3hHZ21PUE5RbE1wZGxpQVNlTmlpem8yQzdpdGJra3FXR2RMd2FpdkZCZDFZNDVJZnpBd1FLa0luMUprNlRpcl8yNl9yMmhn?oc=5","date":"2023-12-12","type":"pipeline","source":"Johns Hopkins Medicine","summary":"Urine \"Liquid Biopsies\" for Bladder Cancer - Johns Hopkins Medicine","headline":"Urine \"Liquid Biopsies\" for Bladder Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPRnBpNW1NcE1iN2hRQnFXeWJaaTh6SkNMNzMybGc3T21INWN1SV85TUtjUmdlYzRjSHowZTVBTDRneU9hcnQ3dFhQYlVMaUxyWlBvUFNjYW1FY1FhM0RHTDEydVhlTE1iZXB4ZHZOT0U2R3FnRHI4QmZEc3BPUDNzNzlWMEd5ZmtTcGpVSnRWMzVQWGlpWU4ySFNaQlAybXNBaTRva3MxUkVBN3hMc0pBVXEwelMzQmhr?oc=5","date":"2022-10-17","type":"pipeline","source":"ASCO Daily News","summary":"Managing Bladder Cancer: Chemotherapy Ineligibility Compared With Cisplatin Ineligibility - ASCO Daily News","headline":"Managing Bladder Cancer: Chemotherapy Ineligibility Compared With Cisplatin Ineligibility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5HaTJCd2VpRC1nR2R4Y3k2UDRzUENKdXg3Zkc1Z29WNE1Jd0xRVGZZMTNJaFJ4ckJYU3EzYVQ2eHE1N3J5dDdiX0t4QXJmbndQbV8yamlTUFlKZF9NZW11Zlhxa3lXMEJ6Nm9NazRrM081cFhBSmg4QjFmUQ?oc=5","date":"2020-08-05","type":"trial","source":"Wiley","summary":"A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer - Wiley","headline":"A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant m","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}